JLM INNOVATION GMBH

Their core work

JLM Innovation is a German SME specializing in advanced sensor technologies for chemical and biological detection, with a strong focus on breath-based medical diagnostics. They develop gas sensors, SERS-based detection systems, and smart sensing platforms that translate nanotechnology research into practical screening tools. Their core commercial value lies in bridging sensor hardware with real-world applications — from non-invasive cancer screening via exhaled breath to rapid chemical threat detection for security scenarios.

What they specialise in

How they've shifted over time

JLM's early work (2015–2019) centered on medical breath diagnostics — detecting tropical diseases and gastric cancer using smartphone-integrated sensors with nanotechnology and microfluidics. In the later period (2019–2023), they retained their breath analysis and cancer screening focus (VOGAS) but branched into security applications with SENSOFT, introducing SERS-based detection, additive manufacturing for flexible substrates, and energy harvesting for autonomous sensor networks. This shows a clear pattern of expanding their core gas sensing expertise from purely medical applications into dual-use security and defense domains.

JLM is moving from lab-oriented medical sensors toward field-deployable, autonomous sensing platforms — making them increasingly relevant for both health screening and security applications.

How they like to work

JLM operates exclusively as a participant, never coordinating projects, which is typical for a specialist SME that contributes specific technical components rather than leading large research agendas. With 36 unique partners across 21 countries in just 4 projects, they work in broad international consortia and do not appear locked into a small partner circle. This wide network suggests they are easy to integrate into new consortia and valued for their specific sensor expertise rather than institutional ties.

Despite only 4 projects, JLM has built a remarkably wide network of 36 partners across 21 countries, indicating they consistently join large, geographically diverse consortia. Their partnerships span well beyond Germany, covering much of Europe and likely extending to non-EU research partners through MSCA-RISE mobility schemes.

What sets them apart

JLM sits at a rare intersection: they combine deep gas sensing and nanotechnology expertise with practical, application-driven product development — both in health diagnostics and security. Unlike university labs that publish papers, JLM as a private SME is oriented toward commercializable sensor platforms, making them a strong partner when a consortium needs to demonstrate real-world impact. Their ability to apply the same core sensing technology across medical screening and chemical threat detection makes them unusually versatile for their size.

Highlights from their portfolio

• SNIFFPHONE
  Largest single grant (EUR 641,850) — ambitious integration of nanosensors into a smartphone platform for gastric cancer screening from breath.
• VOGAS
  Continued and deepened the breath-based cancer screening line with a hybrid VOC sensing approach, showing sustained commitment to commercializing this technology.
• SENSOFT
  Represents a strategic pivot — applying JLM's gas sensing expertise to chemical warfare agent detection, opening the security and defense market.